Efficacy and Safety of Luspatercept in Patients Enrolled in the BELIEVE Trial: Data from the Phase 3b Long-Term Rollover Study

被引：2
|
作者：
Cappellini, Maria Domenica [1 ]
Taher, Ali T. [2 ]
Viprakasit, Vip [3 ]
Georgiev, Pencho [4 ]
Kuo, Kevin H. M. [5 ,6 ]
Holot, Natalia [7 ]
Vilmont, Valerie [8 ]
Medlin, Loyse Felber [8 ]
Kuo, Wen-Ling [7 ]
Lai, Yinzhi [7 ]
Bueno, Luciana Moro [8 ]
Sheth, Sujit [9 ]
机构：
[1] Univ Milan, Fdn IRCCS Ca Granda Policlin Hosp, Milan, Italy
[2] Amer Univ, Dept Internal Med, Beirut Med Ctr, Beirut, Lebanon
[3] Mahidol Univ, Siriraj Res Hosp, Bangkok, Thailand
[4] Med Univ Plovdiv, Plovdiv, Bulgaria
[5] Univ Hlth Network, Div Med Oncol & Hematol, Dept Med, Toronto, ON, Canada
[6] Univ Toronto, Div Hematol, Dept Med, Toronto, ON, Canada
[7] Bristol Myers Squibb, Princeton, NJ USA
[8] Bristol Myers Squibb Co, Celgene Int Sarl, Boudry, Switzerland
[9] Weill Cornell Med, Div Pediat Hematol Oncol, New York, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-174089
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] MRI, Efficacy, and Safety of Tolebrutinib in Highly Active Disease: 2-Year Data from Phase 2b Long-term Safety Study
    Fox, R.
    Oh, J.
    Arnold, D.
    Syed, S.
    Xu, Z.
    Turner, T.
    Traboulsee, A.
    Reich, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 526 - 527
  • [42] Long-term efficacy and safety of idebenone in patients with LHON in the subacute/dynamic phase: Results from the LEROS study
    Klopstock, Thomas
    Tomasso, Livia
    Lloria, Xavier
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [43] A Long-Term Study of Acotiamide in Patients With Functional Dyspepsia: Results From an Open-Labeled Phase III Trial in Japan on Safety and Efficacy
    Matsueda, Kei
    Hongo, Michio
    Ushijima, Satoshi
    Akiho, Hiraku
    Kato, Hiruki
    GASTROENTEROLOGY, 2011, 140 (05) : S805 - S805
  • [44] MRI, efficacy, and safety of tolebrutinib in patients with highly active disease (HAD): 2-year data from the phase 2b Long-term safety (LTS) Study
    Fox, R. J.
    Oh, J.
    Arnold, D. L.
    Syed, S.
    Xu, Z.
    Turner, T. J.
    Traboulsee, A.
    Reich, D. S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 331 - 331
  • [45] MRI, Efficacy, and Safety of Tolebrutinib in Patients with Highly Active Disease (HAD): 2-Year Data from the Phase 2b Long-term Safety (LTS) Study
    Fox, Robert
    Oh, Jiwon
    Arnold, Douglas
    Syed, Sana
    Xu, Zhixing
    Turner, Timothy
    Traboulsee, Anthony
    Reich, Daniel
    NEUROLOGY, 2023, 100 (17)
  • [46] LONG-TERM EFFICACY AND SAFETY OF LOMITAPIDE IN PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME (FCS): DATA FROM THE LOCHNES STUDY
    Giammanco, A.
    Cefalu, A.
    D'Erasmo, L.
    Iannuzzo, G.
    Noto, D.
    Montali, A.
    Zambon, A.
    Forte, F.
    Suppressa, P.
    Giannini, S.
    Barbagallo, C. M.
    Ganci, A.
    Nardi, E.
    Brancatelli, G.
    Caldarella, R.
    Ciaccio, M.
    Arca, M.
    Averna, M.
    ATHEROSCLEROSIS, 2023, 379
  • [47] Assessment of longer-term efficacy and treatment-emergent adverse events (TEAEs) in the phase 3 BELIEVE trial of luspatercept to treat anemia in patients (pts) with β-thalassemia
    Cario, H.
    Taher, A. T.
    Viprakasit, V.
    Cappellini, M. D.
    Hermine, O.
    Georgiev, P.
    Kuo, K. H. M.
    Coates, T.
    Voskaridou, E.
    Liew, H. K.
    Pazgal-Kobrowski, I
    Forni, G. L.
    Perrotta, S.
    Khelif, A.
    Lal, A.
    Kattamis, A.
    Shah, F.
    Porter, J.
    Laadem, A.
    Shetty, J. K.
    Kuo, W-L
    Zhang, J.
    Miteva, D.
    Zinger, T.
    Sinsimer, D.
    Louis, C. U.
    Piga, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 178 - 179
  • [48] DESIGN OF A PHASE 3 TRIAL TO EVALUATE THE LONG-TERM EFFICACY AND SAFETY OF ATALUREN IN PATIENTS WITH NONSENSE MUTATION DUCHENNE MUSCULAR DYSTROPHY
    Trifillis, Panayiota
    Schilling, Traci
    O'Mara, Edward
    McIntosh, Joseph
    MUSCLE & NERVE, 2018, 58 : S59 - S59
  • [49] Design of a phase 3 trial to evaluate the long-term efficacy and safety of ataluren in patients with nonsense mutation Duchenne muscular dystrophy
    Riebling, P.
    O'Mara, E.
    Luo, X.
    Trifillis, P.
    Ong, T.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S218 - S218
  • [50] Design of a Phase 3 Trial to Evaluate the Long-Term Efficacy and Safety of Ataluren in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
    Trifillis, Panayiota
    Riebling, Peter
    O'Mara, Edward
    Luo, Xiaohui
    McIntosh, Joseph
    NEUROLOGY, 2018, 90
12345